Ideal sphere-forming culture conditions to maintain pluripotency in a hepatocellular carcinoma cell lines

Cancer Cell International

Volumn 15, Issue 1, 2015, Pages

  Min, Seon Ok ^a,b   Lee, Sang Woo ^a,b   Bak, Seon Young ^a,b   Kim, Kyung Sik ^a,b,c  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Bovine serum albumin; Hep G2 cells; Neoplastic stem cells; Pluripotent stem cells

Indexed keywords

BETA CATENIN; BOVINE SERUM ALBUMIN; CD133 ANTIGEN; CELL MARKER; CONNEXIN 32; CONNEXIN 43; EPITHELIAL CELL ADHESION MOLECULE; GROWTH FACTOR; THY 1 ANTIGEN; UVOMORULIN;

ARTICLE; CELL PROLIFERATION; CULTURE MEDIUM; FLOW CYTOMETRY; HEPATOCELLULAR CARCINOMA CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 84943656764     PISSN: None     EISSN: 14752867     Source Type: Journal    
DOI: 10.1186/s12935-015-0240-y     Document Type: Article

References (23)

1. Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell. 2012;21(3):283-96.
2. Cohnheim J. Congenitales, quergestreiftes Muskelsarkom der Nieren. Archiv für pathologische Anatomie und Physiologie und für klinische Medicin. 1875;65:64-9.
3. Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell. 1994;77(4):477-8.
4. El-Serag HB. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2001;5(1):87-107 (vi).
5. Oishi N, Yamashita T, Kaneko S. Molecular biology of liver cancer stem cells. Liver Cancer. 2014;3(2):71-84.
6. Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology. 2007;132(7):2542-56.
7. Reynolds BA, Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central-nervous-system. Science. 1992;255(5052):1707-10.
8. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124(4):619-26.
9. Zhu Z, Hao X, Yan M, Yao M, Ge C, Gu J, Li J. Cancer stem/progenitor cells are highly enriched in CD133+ CD44+ population in hepatocellular carcinoma. Int J Cancer. 2010;126(9):2067-78.
10. Yang ZF, Ho DW, Ng MN, Lau CK, Yu WC, Ngai P, Chu PW, Lam CT, Poon RT, Fan ST. Significance of CD90+ cancer stem cells in human liver cancer. Cancer Cell. 2008;13(2):153-66.
11. Suetsugi A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H. Characterization of CD133(+) hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun. 2006;351(4):820-4.
12. Kim J, Jung J, Lee SJ, Lee JS, Park MJ. Cancer stem-like cells persist in established cell lines through autocrine activation of EGFR signaling. Oncol Lett. 2012;3(3):607-12.
13. Cao L, Zhou YM, Zhai BB, Liao J, Xu W, Zhang RX, Li J, Zhang Y, Chen L, Qian HH, et al. Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol. 2011;11:71.
14. Soeda A, Inagaki A, Oka N, Ikegame Y, Aoki H, Yoshimura SI, Nakashima S, Kunisada T, Iwama T. Epidermal growth factor plays a crucial role in mitogenic regulation of human brain tumor stem cells. J Biol Chem. 2008;283(16):10958-66.
15. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. P Natl Acad Sci USA. 2004;101(3):781-6.
16. Yiben Gu, Jie Fu, Lo Pang-Kuo, Wang Shunqi, Wang Qian. Chen H: The effect of B27 supplement on promoting in vitro propagation of Her2/neu-transformed mammary tumorspheres. J Biotech Res. 2011;12(3):7-18.
17. Li GH, Chen ZT, Hu YD, Wei H, Li DZ, Ji H, Wang DL. Autocrine factors sustain glioblastoma stem cell self-renewal. Oncol Rep. 2009;21(2):419-24.
18. Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, Wicha MS. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003;17(10):1253-70.
19. Suzuki A, Oyama K, Fukao K, Nakauchi H, Taniguchi H. Establishment of clonal colony-forming assay system for pancreatic stem/progenitor cells. Cell Transpl. 2002;11(5):451-3.
20. Yamashita T, Budhu A, Forgues M, Wang XW. Activation of hepatic stem cell marker EpCAM by Wnt-beta-catenin signaling in hepatocellular carcinoma. Cancer Res. 2007;67(22):10831-9.
21. Polakis P. Wnt signaling and cancer. Genes Dev. 2000;14(15):1837-51.
22. Kawasaki Y, Omori Y, Li Q, Nishikawa Y, Yoshioka T, Yoshida M, Ishikawa K, Enomoto K. Cytoplasmic accumulation of connexin32 expands cancer stem cell population in human HuH7 hepatoma cells by enhancing its self-renewal. Int J Cancer. 2011;128(1):51-62.
23. Chen Y, Yu D, Zhang H, He H, Zhang C, Zhao W, Shao RG. CD133(+)EpCAM(+) phenotype possesses more characteristics of tumor initiating cells in hepatocellular carcinoma Huh7 cells. Int J Biol Sci. 2012;8(7):992-1004.